Recently, MicroRNA-26b has been shown to suppress the activation of NF-κB signaling and to enhance the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB329. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.